![Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association](https://strongly.mda.org/assets/uploads/2019/03/Neurogene.jpg)
Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association
![NS Pharma Shares Community Letter Announcing Partnership With Capricor and Distribution of CAP-1002 — Jett Foundation NS Pharma Shares Community Letter Announcing Partnership With Capricor and Distribution of CAP-1002 — Jett Foundation](https://images.squarespace-cdn.com/content/v1/589c85db414fb513e708d08d/bfa58802-6ed2-476f-b48d-4b6a517d202a/Capricor.jpg)
NS Pharma Shares Community Letter Announcing Partnership With Capricor and Distribution of CAP-1002 — Jett Foundation
![StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD) StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD)](https://yuzu-studypages-prod-east.s3.amazonaws.com/study_banners/1201.jpg)
StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD)
![Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X](https://biotechhealthx.com/wp-content/uploads/2021/09/Capricor-Therapeutics-To-Present-Final-HOPE-2-Trial-CAP-1002-Data-for-Late-Stage-Duchenne-Muscular-Dystrophy-DMD.jpg)
Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X
![Leukocyte counts and inflammatory markers in patients receiving CAP-1002 | Download Scientific Diagram Leukocyte counts and inflammatory markers in patients receiving CAP-1002 | Download Scientific Diagram](https://www.researchgate.net/publication/341322168/figure/tbl1/AS:890418644402176@1589303756269/Leukocyte-counts-and-inflammatory-markers-in-patients-receiving-CAP-1002.png)
Leukocyte counts and inflammatory markers in patients receiving CAP-1002 | Download Scientific Diagram
![Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place](https://assets.suredone.com/684280/media-photos/sd00002017-fuel-off-road-chrome-aftermarket-8-lug-center-cap-1002-53-cap-m-698-cap-m-721.jpg)
Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place
![Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy](https://www.parentprojectmd.org/wp-content/uploads/2021/09/capricor-blog.png)
Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy
![Stream episode Capricor's CAP-1002 - COVID-19 Survival of Critical Patients by Health Professional Radio podcast | Listen online for free on SoundCloud Stream episode Capricor's CAP-1002 - COVID-19 Survival of Critical Patients by Health Professional Radio podcast | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-xG46ZzhvIOpI1xZc-qDIs6A-t500x500.png)